Enhabit (EHAB) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
23 Feb, 2026Executive summary
Agreement reached for acquisition by Kinderhook Industries, a middle-market private equity firm, with announcement made to employees and leadership.
Day-to-day operations, team structures, strategy, and mission are expected to remain unchanged through the transition.
Transaction expected to close in the second quarter of 2026, pending shareholder and regulatory approvals.
Employees holding stock will receive $13.80 in cash per share, including for unvested equity, upon closing.
Communication emphasizes continuity, transparency, and timely updates throughout the process.
Voting matters and shareholder proposals
Shareholder approval is required for the transaction to proceed, with a special meeting to be announced.
Proxy materials, including a proxy statement, will be filed with the SEC and made available to investors.
Board of directors and corporate governance
Directors and executive officers may be deemed participants in the solicitation of proxies for the transaction.
Information about directors and officers is available in the company's definitive proxy statement for the 2025 annual meeting.
Latest events from Enhabit
- Pending merger with Kinderhook Industries follows a year of revenue growth and operational improvement.EHAB
Proxy Filing5 Mar 2026 - Revenue and EBITDA rose, leverage fell, and a merger is pending.EHAB
Q4 20255 Mar 2026 - Acquisition by Kinderhook Industries prompts shareholder vote and transition to private ownership.EHAB
Proxy Filing26 Feb 2026 - Pending acquisition will take the company private, subject to shareholder approval in 2026.EHAB
Proxy Filing23 Feb 2026 - Stockholders to receive $13.80 per share in a $1.1B buyout, pending approvals.EHAB
Proxy Filing23 Feb 2026 - Adjusted EBITDA rose 5.4% as non-Medicare admissions and hospice growth offset revenue softness.EHAB
Q2 20242 Feb 2026 - Growth driven by payer contract expansion, operational efficiency, and disciplined capital use.EHAB
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Diversified contracts and operational gains drive growth despite Medicare headwinds.EHAB
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Adjusted EBITDA up 5.6%, but goodwill impairment drove a $110.2M net loss; hospice grew 11%.EHAB
Q3 202416 Jan 2026